Thalassemia Reports (Jun 2022)

The Effect of COVID-19 on Hemoglobinopathy Patients’ Daily Lives While Quarantined: Four Greek Hospitals’ Experiences

  • Sophia Delicou,
  • Aikaterini Xydaki,
  • Konstantinos Manganas,
  • Emmanouil Koullias,
  • Loukia Evliati,
  • Chryssoula Kalkana,
  • Michael D. Diamantidis,
  • Achilles Manafas,
  • Marianna Katsatou,
  • Leonidas Roumpatis,
  • Theodoros Aforozis

DOI
https://doi.org/10.3390/thalassrep12020008
Journal volume & issue
Vol. 12, no. 2
pp. 39 – 45

Abstract

Read online

During a pandemic, people are fearful of becoming infected with the virus, which causes anxiety, loss of purpose, and depression. This study aimed to evaluate the social and psychological impact, as well as the impact on homecare, of patients with hemoglobinopathies during the pandemic. Material and Methods: In total, 130 patients from four Thalassemia and Sickle Cell Disease Units of the National Health System of Greece Hospitals were examined via an anonymous questionnaire developed and distributed through stratified sampling. Results: Transfusion-dependent thalassemia, transfused sickle cell disease, and other hemoglobinopathies were represented by 130 patients. During the pandemic, the main concern of patients was the affordability of blood for transfusion. During the lockdown, patients’ moods varied, and their daily lives were disrupted by a lack of access to basic goods and communication with friends and family. Their eating habits, access to exercise, and, to a lesser extent, their financial situation have all been affected in their daily lives. It is crucial to highlight that while access to health services did not suffer in terms of medication and regular visits for their actual disease, it did suffer in terms of the systematic monitoring of complications.

Keywords